Y. Naito et al., The inducible nitric oxide synthase inhibitor ONO-1714 blunts dextran sulfate sodium colitis in mice, EUR J PHARM, 412(1), 2001, pp. 91-99
In mice with acute dextran sulfate sodium colitis, we examined the effect o
f inducible nitric oxide synthase inhibition by (1S,5S,6R,7R)-7chloro-3-ami
no-5methyl-2-azabicyclo[4.1.0]heptane hydrochloride (ONO-1714) on colonic b
iochemistry, injury, and inflammation. Colonic luminal nitrate and nitrite
were measured by the Griess reaction; inducible nitric oxide synthase messe
nger RNA expression by reverse transcription-polymerase chain reaction; and
nitrotyrosine by immunohistochemistry. Mice with colitis showed increases
in nitrate and nitrite, inducible nitric oxide synthase messenger RNA, and
numbers of cells staining for nitrotyrosine. Colonic inflammation was sever
e. ONO-1714 inhibited increases in nitrate and nitrite and numbers of nitro
tyrosine-positive cells, injury and inflammation also were reduced. Dextran
sulfate sodium-induced increases in thiobarbituric acid-reactive substance
s, a lipid peroxidation marker, were blunted by ONO-1714, which also inhibi
ted increases in mucosal inflammatory cytokines. Nitric oxide produced by i
nducible nitric oxide synthase may contribute to colonic inflammation by ni
trosation, oxidative damage, and enhanced inflammatory cytokines. (C) 2001
Elsevier Science B.V. All rights reserved.